lyell immunopharma inc - AOMR

AOMR

Close Chg Chg %
8.27 -0.10 -1.21%

Open Market

8.17

-0.10 (1.21%)

Volume: 51.96K

Last Updated:

Sep 10, 2026, 10:28 AM EDT

Company Overview: lyell immunopharma inc - AOMR

AOMR Key Data

Open

$8.25

Day Range

8.17 - 8.25

52 Week Range

7.96 - 9.93

Market Cap

$192.92M

Shares Outstanding

23.21M

Public Float

17.26M

Beta

1.19

Rev. Per Employee

N/A

P/E Ratio

11.18

EPS

$0.78

Yield

1,555.29%

Dividend

$0.32

EX-DIVIDEND DATE

Aug 21, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

148.00K

 

AOMR Performance

1 Week
 
-0.60%
 
1 Month
 
-7.50%
 
3 Months
 
-2.13%
 
1 Year
 
-15.37%
 
5 Years
 
-54.44%
 

AOMR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 10.55
Number of Ratings 6 Current Quarters Estimate 0.32
FY Report Date 09 / 2026 Current Year's Estimate 1.241
Last Quarter’s Earnings 0.371 Median PE on CY Estimate N/A
Year Ago Earnings 0.59 Next Fiscal Year Estimate 1.413
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 6 6 6
Mean Estimate 0.32 0.34 1.24 1.41
High Estimates 0.36 0.37 1.30 1.50
Low Estimate 0.27 0.31 1.15 1.30
Coefficient of Variance 10.79 6.66 4.30 4.74

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 4
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Lyell Immunopharma Inc - AOMR

Date Name Shares Transaction Value
May 27, 2026 Wesley Denny Minami Director 80,318 Open market or private purchase of non-derivative security Non-derivative transaction at $8.15 per share 654,591.70

Lyell Immunopharma Inc in the News